Dr. Olulana O. OLADAPO

Basic Information

 Shokunmbi

Name: Dr. Olulana O. OLADAPO

Faculty: BASIC MEDICAL SCIENCES

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Department: Anatomy

 Designation: Reader

Brief Biography:

Resume

Not Available

Researches

 Research Activities

·         Senate research grants, World Health Organization HQ and Country Office Mitral Valve Prolapse in young female Nigerians

·         (Senate research grant SRG /COM 1996/2A 7/3/2001).        

·         Evaluation of WHO CVD-Risk Management Package Scenario One 

·         (October 2004- March 2006)

·         Asomex (s-amlodipine) versus Norvasc (amlodipine besylate) in the treatment of mild moderate hypertension.

·         Protocol no: FHL/MM/ASOMEX/01(Date:  15/08/2007

·         Cardiovascular risk determinants of Carotid artery intima­ media thickness (a noninvasive)

Publications

  • Selected Peer-reviewed Publications

    (i)      Dissertation and Thesis:

    Years

    Authors

    Title

     

    June 1976

    John Olulola Olutoyin

    Effects of hormones on water absorption in the isolated intestine of Tilapia nilotica.  

    In partial fulfillment of BSc Degree Programme.         

    September 1992

    Oladapo Olulola Olutoyin.

    Detection and localization of CYPIAI/CYPIA2 in murine liver.

    In partial fulfillment of M.Sc. Degree programme.  

    April 1999

    Oladapo Olulola Olutoyin.

    Serum and Urinary concentrations of magnesium in adult Nigerians with congestive heart failure.  

    In partial fulfillment of Fellowship of West African College of Physicians (FWACP).

    (ii) Articles that have already appeared in Learned Journals:

    Year

    Author

    Title

    Journals

    Vol: Pages

    Population based studies on cardiometabolic risk factors using hypertension as entry-point

    2004

    Mendis S., Abegunde D., Oladapo O., Celluti F., Nordet P.

    Barriers to management of cardiovascular risk in low-resource setting using hypertension as an entry point.

    J Hypertens.

    22(1): 59-64.

    2010

    Oladapo OO,  Salako L,  Sodiq O, Shoyinka K, Adedapo K,  Falase AO,  

     A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey.

    Cardiovasc J Afr 

    21: 26-31

    2010

    2009 Dec 8.

    Mendis S, Johnston SC, Fan W, Oladapo O, Cameron A, Faramawi MF.

    Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial.

    Bull World Health Organ

    Epub.

    88 (6):412-419.

    2012

    Oladapo OO,  Salako L,  Sodiq L, Shoyinka K, Adedapo K,  Falase AO

    . Target organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study. 

    Cardiovasc J Afr

    23(7):379-384.

    2013

    Oladapo OO,  Salako L,  Sadiq O, Shoyinka K,  Falase AO.

    Knowledge of hypertension and other risk factors for heart disease among Yoruba Rural Southwestern Nigerian Population.

    Br J Med Med Res.

    3(4): 993-1003.

    Bedside studies on hypertension, heart failure and its co-morbid factors

    2000

    Oladapo OO., Falase AO.  

    Serum and Urinary Magnesium during Treatment of Patients with Chronic Congestive Heart Failure

    Afr. J. Med. med. Sci.

    29:301-303.

    2000

    Oladapo OO., Falase AO.  

    Congestive Heart Failure and Ventricular Arrhythmias in Relation to Serum Magnesium.  

     Afr. J. Med. med. Sci.;

    29: 265-268.

    2001

    Oladapo OO., Falase AO.

    Prevalence of Mitral Valve Prolapse in Healthy Adult Nigerians as Diagnosed by Echocardiography.

    Afr. J. Med. med. Sci.

    30: 13-16.

    2001

    Falase A.O., Oladapo OO (Corresponding author). Kanu EO.

    Relatively Low Incidence of Myocardial Infarction in Nigerians. ;

    Cardiologie Tropicale.

    27: 45-47.

    2008

    Ebesunun MO, Agbedana EO, Taylor GO, Oladapo OO.

    Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD.

    Appl Physiol Nutr Metab.

    33(2):282-9

    2008

    Adebayo AK, Oladapo OO, Adebiyi AA, Ogunleye OO, Ogah OS, Ojji DB, Aje A, Adeoye MA, Ochulor KC, Enakpene EO,  Falase AO. 

    Changes in left atrial dimension and function and left ventricular geometry in newly diagnosed untreated hypertensive subjects

    .  J Cardiovasc Med  (Hagerstown).

    9(6):561-569.

    2008

    Adebayo AK, Oladapo OO, Adebiyi AA, Ogunleye OO, Ogah OS, Ojji DB, Adeoye  MA, Ochulor KC, Enakpene EO, Falase AO. 

     Characterisation of left ventricular function by tissue Doppler imaging technique in newly diagnosed, untreated hypertensive subjects.

    Cardiovasc J Afr.

     

    2011

    Adenipekun AA, Oladapo O, Elumelu TN.

    Concurrent External Radiotherapy and Doxorubicin Based Chemotherapy in Breast Cancer Patients Any Cardiac Side Effects?

    J Am Sci

    7(6):241-244.

    2004

    Salako BL., Adebiyi AA., Oladapo OO., Ogah OS., Aje  A.

    Left ventricular wall dimensions of people with hypertension on treatment. 

    Tropical Cardiology.

    30/n119:38-41.

    2005

    Adebiyi AA, Aje A, Ogah OS, Ojji DB, Oladapo OO, Falase AO.

    Left Ventricular Diastolic Function Parameters in Hypertensives.

    J. Natl Med Assoc.

    97(1): 41-45.

    2005

    Adebiyi AA, Aje A, Ogah OS, Ojji DB, Dada A, Oladapo OO, Falase AO.  

    Correlates of Left Atrial Size in Nigerian Hypertensives:

    .  Cardiovasc J S Afr.

    16(3):158-161.

    2005

    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.  

    Standard Electrocardiographic Criteria for Left Ventricular Hypertrophy in Nigerian Hypertensives.

    Ethn Dis.

    15(4):578-584

    2006 Jul-Sep

    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.  

    Comparison of Araoye's criteria with standard electrocardiographic criteria for diagnosis of left ventricular hypertrophy in Nigerian hypertensives. 

    West Afr J Med.

    25(3):179-185.

    2006

    Aje A, Adebiyi AA, Oladapo OO, Dada A, Ogah OS, Ojji DB, Falase AO.

    Left ventricular geometric patterns in newly  presenting Nigerian hypertensives: An echocardiographic study.  

    BMC Cardiovasc  Disord 

    6:4

    2006

    Adebiyi AA, Ogah OS, Aje A, Ojji DB, Oladapo OO, Falase AO.

    Echocardiographic reference values in healthy Nigerians

    Nig J Cardiol.

    3(1): 30-36.

    2006

    Ogah OS, Adebiyi AA, Oladapo OO, Aje A, Ojji DB, Adebayo AK.

    Association between Electrocardiographic Left Ventricular Hypertrophy with Strain  Pattern and Left  Ventricular Structure and Function. 

    Cardiology

    106(1):14-21.

    2006

    Adebiyi AA, Ogah OS, Aje A, Ojji DB, Adebayo AK, Oladapo OO, Falase AO

    Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians. 

    BMC Medical Imaging

    6:10

    2008 Jan- Feb

    Ogah OS, Oladapo OO, Adebiyi AA, Adebayo AK, Aje A, Ojji DB, Salako BL, Falase AO.  

    Electrocardiographic left ventricular hypertrophy with strain pattern:  prevalence, mechanisms and prognostic implications.

    Cardiovasc J Afr.

    19(1):39-45.

    2008

    Ojji D, Parsonage W, Dooris M, Adebiyi A, Oladapo O, Adeleye J, Aje A, Ogah O, Adebayo A, Falase A, Atherton J.  

     Left ventricular diastolic function in normotensive type-2 diabetic subjects.

    J Natl Med Assoc.

    100(9):1066-1072.

    2009

    Ojji DB, Adebiyi AA, Oladapo OO, Adeleye JA, Aje A, Ogah OS, Adebayo AK, Falase AO.

    Left Ventricular Geometric Patterns in Normotensive Type 2 Diabetic Patients in Nigeria: An Echocardiographic Study.

    Prev Cardiol.

    12(4):184-188.

    2009

    Aje A, Adebiyi AA, Oladapo OO, Ogah OS, Dada A, Ojji DB, Adebayo AK, Adeoye AM, Enakpene EO, Falase AO. 

    Audit of Echocardiographic Services at the University College Hospital Ibadan.

    Niger J Med.

    18(1):32-34

    2009

    Salako BL, Ogah OS, Adebiyi AA, Oladapo OO, Aje A, Adebayo AK, Ojji DB, Ipadeola A, Nwafor CE.

    Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians.

    Ann Afr Med.

    8(3):156-162

    2009

    Adebayo AK, Adebiyi AA, Oladapo OO, Ogah OS, Aje A, Ojji DB, Falase AO. 

    Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria.  

    BMC Cardiovascular Disorders 

    9:52 doi:10.1186/1471-2261-9-52

    2012

    Adeoye AM, Adebiyi AA, Oladapo OO, Ogah OS, Aje A, Ojji DB, Adebayo AK, Ochulor KC, Enakpene EO, Falase AO.

    Early diastolic functional abnormalities in normotensive offspring of Nigerian hypertensives. ;

    Cardiovasc J Afr 

     23: 255–259.

    Post-mortem morphometry of atherosclerosis

    2011

    Olusakin J, Goji A.D.T, Ezekiel I, Oladapo OO, Ogun G.O, Dare S.S, Mesole S.B,Mohammed Y.G.

    Evaluation of Some Risk Factors for Atherosclerosis in the Circle of Willis Observed at Autopsy in University College ‘hospital, Ibadan, Nigeria. 

    Asian J Medical Sciences

    3(5): 186-191

    2012

    Erete EI, Ogun GO, Oladapo OO (Corresponding author), Akang EEU.

    Prevalence and severity of atherosclerosis in extra cranial carotid arteries in Nigeria: an autopsy study.

    BMC Cardiovasc Disorder

    16;12:106. doi: 10.1186/1471-2261-12-106.

    2013

    Olulola Olutoyin Oladapo, Jimmy Olusakin, Gabriel Olabiyi Ogun, Effiong Akang

    Atherosclerosis of the intracranial carotid arteries in Nigerians: A pilot autopsy study. 

    Nig J Cardio.

     

    Toxicology and induction of liver enzymes using animal models

    1995

    Oladapo OO, Forkert PG.

    Changes in Endoplasmic Reticulum Associated with b-naphthoflavone-induced Cytochrome P450 in Murine Liver: A Quantitative Analysis.

    Afr. J. Med. med. Sci.

    24: 389 – 394.

    1995

    Oladapo OO, Forkert PG.  

    Detection and Localisation of CYPIA1/CYPIA2. in Murine Liver: Electrophoresis, Immunoblotting and Immunocytochemistry

    .  Afr. J. Med. med. Sci.

    24: 395 – 402.

    2009

    Osunwoke EA, Oladapo OO, Zamide EI, Oladipo GS.

    A Study on some effects of the extracts of unripe pawpaw (Carica papaya linn) on wound healing in Wistar rats (Rattus novegicus).

    Port Har Med J.

    3:296-301.

    2010

    Amao SY, Ajani RS, Oladapo OO.

    The effects of Cassia alata on the morphology and histoarchitecture of the wistar rat liver.

    Af J Biomedical Research.

    13(3)

    Other studies

    2008

    Adetona MO,  Oladapo OO, Igbigbi PS.  

    Palmar and digital dermatoglyphic patterns of the three major ethnic groups in Nigeria.

    Afr. J. Med. med. Sci.

    37: 333-337.

    2011

    Ajani RS, Oladapo O.

    Attitudes and perception of medical and dental preclinical undergraduates in a Nigerian medical school towards cadaveric dissection.

    Sci. Afr. J Med med

    40(2):139-146.

    Case report

    2008

    Ogah OS, Ogunbiyi OA, Adebiyi AA, Oladapo OO, Okolo CA, Adeyemi FB, Adeoye AM, Aje A, Ojji BD, Falase OA.

    Amyloidosis with cardiac involvement in a 54-year old Nigerian: a case report.

    Nig J Cardiol.

    5(2): 38-43.

    (iii)        Articles already appeared in referred conference proceedings:

    2004

    Aje A, Adebiyi A, Oladapo OO., Ogah OS, Dada A, Ojji DB, Falase AO.

    Left ventricular geometric patterns in Nigerians with hypertension seen in UCH, Ibadan.

    Cardiovasc J S Afr.

    15(5): 223-224.

    2012

    Oladapo O.O, Salako L, Sadiq L, Shoyinka K, Falase A O. 

    Knowledge of risk factors for heart disease among yoruba community of Nigeria.

    Circulation.

    P306

    2012

    Enakpene E O, Adebiyi AA, Ogah O S,  Oladapo OO, Aje   A, Adeoye M A, Falase A O. 

    Left ventricular structure and function in haemoglobin ss (sickle cell anemia) subjects in Ibadan, Nigeria.

    Circulation.

    P350

    (iv)Technical Reports and Monographs

     

    Oke DA,  Oladapo O, Danbauchi SS,  Ohunbere BJC,  Olayemi S,  Ekpegbeh CO.  

    A comparative cross over trail of Asomex (S-Amlodipine) and Norvasc (Amlodipine besylate) in the treatment of mild to moderate hypertension.

    Protocol

    No: FHL/MM/ASOMEX/01

    9-12 July 2002

     

    Integrated Management of Cardiovascular Risk:

    Report of a WHO meeting, Geneva, ISBN 92 4 156224 2 (NLM classification: WG 166) World Health Organization 2002. (Percentage contribution 50%).       

 

Contact Information

 Phone: 08023509732

 Address:

 Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 FacebookProfile Link

 LinkedInProfile Link

 TwitterProfile Link

 InstagramProfile Link

 YouTubeProfile Link

PinterestProfile Link


Social Links

Get In Touch